Strategic management

Mennta Energy Solutions Announces the Premiere of its New Executive Level Climate Change and ESG Course

Retrieved on: 
Wednesday, February 7, 2024
Climate change, Curriculum, ESG, Research, Strategic management, Sustainability, Carbon, Corporation, FRM, Alpha, CFA, Organization

PRINCETON, N.J., Feb. 7, 2024 /PRNewswire-PRWeb/ -- Pioneers and market leaders in energy education and training, Mennta Energy Solutions, has announced the debut of their new course 'The Impact of Climate Change & ESG on Corporate Strategy & Finance'. Led by award-winning ESG research manager Gabriel Thoumi, CFA, FRM, Certified Ecologist, Founder and CEO of Responsible Alpha, this intensive course is designed to guide corporate executives and leaders through the dynamic world of sustainable finance, ESG, climate risk, Nature-based Solutions, and corporate strategy in the 'Era of Sustainability'.

Key Points: 
  • PRINCETON, N.J., Feb. 7, 2024 /PRNewswire-PRWeb/ -- Pioneers and market leaders in energy education and training, Mennta Energy Solutions, has announced the debut of their new course 'The Impact of Climate Change & ESG on Corporate Strategy & Finance'.
  • "Climate change and ESG risk mitigation can immediately generate risk-adjusted financial returns and improve corporate strategies.
  • "Corporate sustainability responsibilities and the subsequent opportunities have matured rapidly in recent years," states Clara Spinetto, President and CEO, Mennta Energy Solutions.
  • This course will guide elite professionals through the potential economic and operational impacts of sustainability, ESG, and climate risks and opportunities in their organizations.

Exelon Digital Transformation strategy Insights Report 2023 - Innovation Programs, Technology Initiatives, Estimated ICT Budget, and Major ICT Contracts

Retrieved on: 
Monday, February 5, 2024
ICT, Public sector, AI, Wind, Strategic management, Sustainability, Biomass, Digital, ChargePoint, Investment, EV, Electricity, Natural gas

This report provides insight into Exelon's tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its estimated ICT budget, and its major ICT contracts.

Key Points: 
  • This report provides insight into Exelon's tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its estimated ICT budget, and its major ICT contracts.
  • The company produces electricity using nuclear, natural gas, oil, wind, hydro, solar, and biomass sources; and purchases electricity through long-term power purchase contracts.
  • Exelon is strengthening its digital culture through key technology hires, innovation programs, and digitizing its workspace.
  • For instance, the firm has introduced the Corporate Strategy, Innovation, and Sustainability group to enhance its internal culture of innovation.

Aprea Therapeutics to Present at DDR Inhibitors Summit 2024

Retrieved on: 
Tuesday, January 30, 2024
Strategic management, APRE, Summit, Therapy, SVP, Cancer, Pharmaceutical industry

DOYLESTOWN, Pa., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that Dr. Oren Gilad, President and CEO, will deliver a presentation at the 7 th DDR Inhibitors Summit , to take place January 30 to February 1, 2024 in Boston, MA.

Key Points: 
  • DOYLESTOWN, Pa., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that Dr. Oren Gilad, President and CEO, will deliver a presentation at the 7 th DDR Inhibitors Summit , to take place January 30 to February 1, 2024 in Boston, MA.
  • “We are excited to have the opportunity to present at the DDR Inhibitors Summit,” said Dr. Oren Gilad.
  • “DDR has been identified as an important pathway for treating cancer, and there is considerable ongoing progress in the development of potential new therapeutics.
  • Aprea is positioned at the forefront of this wave of innovation, and we look forward to providing an update to the oncology community at this year’s summit.”
    Brian Wiley, SVP of Corporate Strategy at Aprea, will also be attending the Summit and will be available for 1on1 meetings.

Cirba Solutions and EcoPro Innovating the Closed-Loop Circular Battery Economy

Retrieved on: 
Thursday, February 1, 2024
Inflation, Growth, CAM, Recycling, Strategic management, PCAM, Collection

CHARLOTTE, N.C., Feb. 1, 2024 /PRNewswire/ -- Cirba Solutions, the premiere battery recycling and battery materials company, is collaborating with EcoPro Co Ltd ("EcoPro"), a global leader in lithium-ion battery cathode materials, under a signed Memorandum of Understanding ("MOU") to enhance innovative elements of the lithium-ion battery recycling business.

Key Points: 
  • CHARLOTTE, N.C., Feb. 1, 2024 /PRNewswire/ -- Cirba Solutions, the premiere battery recycling and battery materials company, is collaborating with EcoPro Co Ltd ("EcoPro"), a global leader in lithium-ion battery cathode materials, under a signed Memorandum of Understanding ("MOU") to enhance innovative elements of the lithium-ion battery recycling business.
  • With the growing demand for critical battery materials, strategic alliances play a crucial role as the circular battery supply chain continues to develop around the world.
  • EcoPro will leverage Cirba Solutions recycled materials to produce precursor cathode active material (PCAM) and cathode active material (CAM).
  • "Working with a world-renowned team like EcoPro supports the expansion of an interconnected battery supply chain."

TeamSnap Partners with SquadLocker to Bring Custom Apparel to Players, Families, and Fans

Retrieved on: 
Tuesday, January 30, 2024
Community, Nike, Partnership, API, Ship, Ecosystem, Sport, Parent, Strategic management, SVP

WARWICK, R.I., Jan. 30, 2024 /PRNewswire/ -- SquadLocker, the leading custom team apparel software and fulfillment service, announced a strategic partnership with TeamSnap, the leading provider of sports management software and online community for everything youth sports.

Key Points: 
  • TeamSnap partners with SquadLocker, offering users custom apparel, spirit wear, uniforms, and gear via the mobile app.
  • "With this partnership, we're excited that every new team created through the TeamSnap mobile app will get a ready-to-shop Team Store made possible through the SquadLocker Partner API.
  • Each Team Store includes sports-specific gear that can be further customized by the team with logos, required kits, and fundraising," said Fletcher Jones, Chief Product Officer at SquadLocker.
  • We are combining the impressive reach of TeamSnap's youth sports ecosystem with the rich capabilities of SquadLocker's easy-to-use and highly customizable team apparel solution," said George Overholser, CEO at SquadLocker.

SIRPant Immunotherapeutics Strengthens Board of Directors with Appointment of Roger Sawhney, M.D.

Retrieved on: 
Monday, January 22, 2024
Senior, Stanford University, Therapy, KKR, Bone marrow, Drug discovery, Business development, IND, Investment, Novartis, Harvard Medical School, Strategic management, Medical device

HUMMELSTOWN, Pa., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SIRPant Immunotherapeutics, Inc., a clinical-stage immuno-oncology company focusing on developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors, today announced the appointment of Roger Sawhney, M.D.

Key Points: 
  • HUMMELSTOWN, Pa., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SIRPant Immunotherapeutics, Inc., a clinical-stage immuno-oncology company focusing on developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors, today announced the appointment of Roger Sawhney, M.D.
  • to its Board of Directors.
  • Dr. Sawhney brings nearly 30 years of financial and strategic expertise spanning the biopharma industry.
  • His expertise in cell therapy will be particularly valuable to SIRPant as we advance SIRPant-M™, our lead product candidate, into clinical development,” said Robert Towarnicki, President & CEO of SIRPant.

Acorn Influence Appoints Blake Marts as New VP of Corporate Strategy to Spearhead Product Development and Integration of Acquisition Capabilities

Retrieved on: 
Thursday, January 18, 2024
Marts, Social media, Partnership, Athlete, NIL, Sport, Product marketing, Acorn, Marketing, Strategic management, Growth, Sales

SEATTLE, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Acorn Influence, a New Engen company and influencer solution provider, has appointed Blake Marts as VP of Corporate Strategy, to oversee growth strategy, product development and commercialization, and technology.

Key Points: 
  • SEATTLE, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Acorn Influence, a New Engen company and influencer solution provider, has appointed Blake Marts as VP of Corporate Strategy, to oversee growth strategy, product development and commercialization, and technology.
  • Working in partnership with Acorn Influence and New Engen leadership, Marts will also help identify strategic opportunities for the organization, ultimately overseeing the integration of acquired capabilities within the greater agency.
  • This appointment highlights Acorn Influence and New Engen’s commitment to harmonizing their business strategies and product development as a whole.
  • “As Acorn Influence continues to bring its strategic roadmap to market, we could not be more thrilled to welcome Blake to the team,” said Heather Nichols, Chief Executive Officer at Acorn Influence.

Medical Devices Sector Delivers Stent Retrievers Pipeline Report with Global Industry Analysis 2023 - ResearchAndMarkets.com

Retrieved on: 
Monday, January 29, 2024
Medical Devices, Health, Strategic management, Research, Collection

The "Stent Retrievers Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Stent Retrievers Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.
  • A report providing a detailed overview of the stent retrievers market has been added to the expansive collection of industry analysis documents.
  • This report offers profound insights into the stent retrievers pipeline, inclusive of products at various stages of development, as well as comprehensive data on ongoing clinical trials.
  • Extensive Product Coverage and Developmental Analysis: The analyses within the report encompasses a spectrum of stent retrievers currently under development.

Insigneo appoints Michael Averett as Chief Revenue Officer

Retrieved on: 
Monday, January 29, 2024
Finance, Consulting, Professional Services, Other Professional Services, Asset Management, Strategic management, Head, Multimedia, Citigroup, Business development, Series 7, Thunderbird, Growth

Insigneo, a leading global wealth management firm, is pleased to announce the appointment of Michael Averett as Chief Revenue Officer (CRO).

Key Points: 
  • Insigneo, a leading global wealth management firm, is pleased to announce the appointment of Michael Averett as Chief Revenue Officer (CRO).
  • As CRO, Mr. Averett will be overseeing the firm's revenue-generating facets and actively driving the company’s organic growth strategy.
  • View the full release here: https://www.businesswire.com/news/home/20240129012834/en/
    Michael Averett, Chief Revenue Officer (CRO) (Photo: Business Wire)
    Michael Averett brings to Insigneo more than two decades of experience in financial services, concentrated in the United States as well as in Latin America.
  • I look forward to fostering revenue growth and am excited to play a part in fortifying Insigneo's position as an industry leader.” Commented Michael Averett, Chief Revenue Officer of Insigneo.

CACI Reports Results for Its Fiscal 2024 Second Quarter and Raises Fiscal Year Guidance

Retrieved on: 
Wednesday, January 24, 2024
Technology, Other Defense, Contracts, Security, Other Technology, Aerospace, Software, Manufacturing, Networks, Defense, Engineering, Assistant, State, ESI, MARPA, PEO, Growth, IDIQ, CACI, C4, Computer, Environment, GAAP, Investment, Tax, National Guard, Department of Defence, System integration, Workforce, DSO, Strategic management, DCGS, Army, EATS, Arms industry

Revenues in the second quarter of fiscal year 2024 increased 11.2 percent year-over-year, essentially all organic growth.

Key Points: 
  • Revenues in the second quarter of fiscal year 2024 increased 11.2 percent year-over-year, essentially all organic growth.
  • Contract awards in the second quarter totaled $2.2 billion, with approximately 55 percent for new business to CACI.
  • The table below summarizes our fiscal year 2024 guidance and represents our views as of January 24, 2024.
  • Our revenue guidance reflects approximately $200 million of higher-than-expected material purchases by our customers, split evenly between the first and second quarters of fiscal year 2024.